New study aims to make prostate cancer treatment less tiring
NCT ID NCT06274047
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 30 times
Summary
This study tests whether giving a personalized dose of the drug apalutamide, based on how aggressive the cancer is, can reduce fatigue and other side effects in men who have had prostate surgery and are getting radiation therapy. About 120 men with detectable PSA after surgery will take part. The goal is to improve quality of life while still controlling the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact Email: •••••@•••••
Contact
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Kansas Medical Center
RECRUITINGKansas City, Kansas, 66103, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.